Identifying the optimum first-line therapy in BRAF-mutant metastatic melanoma

Dimitrios C. Ziogas,Frosso Konstantinou,Spyros Bouros,Helen Gogas

Identifying the optimum first-line therapy in BRAF-mutant metastatic melanoma

2020

Dimitrios C. Ziogas
Frosso Konstantinou
Spyros Bouros
Helen Gogas

ABSTRACTIntroduction: The emergence of molecularly targeted agents and immune checkpoint inhibitors has positively revolutionized the management and prognosis of BRAF-mutant metastatic melanoma. Ho...

Keywords:

first line
Immune checkpoint
Mutant
Immunotherapy
first line therapy
Medicine
Cancer research
Immunology
metastatic melanoma
Targeted therapy
immune checkpoint inhibitors

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations